Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model-Reference-Cited by-同舟云学术

Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model

Published:2018-06 Issue: Volume:154 Page:149-157
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Caidi Hayat,Miao Congrong,Thornburg Natalie J.^ORCID,Tripp Ralph A.^ORCID,Anderson Larry J.,Haynes Lia M.

Funder

CDC Foundation

University of Georgia

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference46 articles.

1. Epidemiological aspects of respiratory syncytial virus (RSV) infections in Italy: a national survey;Alvaro;J. Int. Med. Res.,2000

2. Strategic priorities for respiratory syncytial virus (RSV) vaccine development;Anderson;Vaccine,2013

3. An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice;Boyoglu-Barnum;Virology,2015

4. An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice;Boyoglu-Barnum;Virology,2015

5. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development;BS;Immunol. Rev.,2011

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs and human viral diseases: A focus on the role of microRNA-29;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2025-01

2. Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement;Immunological Reviews;2024-09-13

3. KD-409, a Respiratory Syncytial Virus FG Chimeric Protein without the CX3C Chemokine Motif, Is an Efficient Respiratory Syncytial Virus Vaccine Preparation for Passive and Active Immunization in Mice;Vaccines;2024-07-08

4. Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus;Viruses;2024-05-24

5. Preclinical animal models to evaluate therapeutic antiviral antibodies;Antiviral Research;2024-05